Credits: Instagram & Canva
Dr Joe Whittington, who goes by Dr Joe on his social media platforms is a certified MD in Emergency Medicine based in Apple Valley, California is a social media medical educator. He uploads many real-life health-related stories and cases to educate general public about it. In one such videos, he featured a woman who just had her baby four days ago and found out that she was four months pregnant.
Dr Joe says, "technically, yes". This phenomenon is known as superfetation that occurs when a woman releases an egg and it gets fertilized and implanted after she is already pregnant.
He says, "Usually pregnancy changes such as hormonal changes, changes in the uterus, and the cervical mucous plug all work to prevent this. So superfetation is extremely rare with only about 10 documented cases. But, it is possible."
It is a rare phenomenon where a second pregnancy occurs alongside an existing one. This happens when another ovum or the egg is fertilized by sperm and implanted in the womb days or weeks later than the first one. Babies born from superfetation are often considered twins as they may be born on the same birth on the same day. However, not always does it happen. In the case that Dr Joe picked up, the baby had a difference of four months.
ALSO READ: Pregnancy Trimesters, Everything You Need To Know About It
In humans, pregnancy occurs when an egg is fertilized by sperm and implants in the uterus. For superfetation to happen, a second egg must be fertilized and implanted separately while a pregnancy is already underway.
For this to occur, three highly unlikely events must take place:
Ovulation during an ongoing pregnancy – This is rare because pregnancy hormones typically prevent further ovulation.
Fertilization of the second egg – Once pregnant, a woman’s cervix forms a mucus plug that blocks sperm from entering, making fertilization extremely unlikely.
Implantation in an already pregnant uterus – Implantation requires specific hormonal changes that usually don’t occur once pregnancy has begun.
Additionally, a growing fetus takes up space, making it harder for another embryo to implant.
Because these conditions are so improbable, superfetation is considered nearly impossible in natural pregnancies. However, a few reported cases exist, primarily in women undergoing fertility treatments like in vitro fertilization (IVF). In such cases, an embryo is transferred into the uterus, but if ovulation unexpectedly occurs and the egg is fertilized, superfetation might happen a few weeks later.
The biggest complication with superfetation is premature birth. The baby maybe born before time and could have the following medical conditions:
Women too could have complication, which includes high blood pressure and protein in the urine, a condition called preeclampsia, and gestational diabetes.
Credits: Instagram
Vanessa Hudgens at the age of 36 is a mother again. She welcomed her second baby with husband Cole Tucker. The news was announced on Instagram on Saturday, where she shared a photo of herself lying in a hospital bed, holding Tucker's hand.
She wrote: "Well…. I did it. Had another baby!! What a wild ride labor is. Big shout out to all the moms. It’s truly incredible what our bodies can do ❤️."
This month itself, Catherine Paiz revealed that she was pregnant with her fourth baby at the age of 35.
These news of celebrity pregnancy after 30 spark the spotlight on late motherhood and how safe it really is?
The average age of mothers in the US have continued to rise, a new report released on June 13 by the National Vital Statistic System (NVSS), provides the shift in age trends between 2016 and 2023. The study, conducted by Andrea D. Brown, Ph.D., M.P.H., and her colleagues at the National Center for Health Statistics.
The researchers found a clear increase in the mean age of mothers at the time of their first birth. In 2016, the average age of a first-time mother was 26.6 years. By 2023, this had risen to 27.5 years — nearly a full year’s difference in just seven years.
But the trend isn’t limited to first-time mothers. In Paiz's case, she is having her fourth child at 35.
The National Institute of Health (NIH), US (2022), 20% of women in the US are now having their first child after the age of 35. While it is the new trend, the NIH doctor Dr Alan Decherney, a fertility expert explains that "As women age, they are still fertile, but their odds of pregnancy are decreased because they are not making as many good eggs that will fertile and divide normally and turn out to be an embryo."
After age 30, a woman's fertility decreases ever year, notes the NIH July 2022 issue. It notes: "The number and quality of her eggs goes down until she reaches menopause."
However, experts do point out that getting pregnant in your 30s need not be a stressful affair at all times. As it is at this age when you experience more stability, and also someone you know who have a personal experience in handling one. Most important, you are more mature at this age, which you may not be in your 20s.
Quit Habits: If you are a smoker, or consume alcohol, this is a good time to leave it.
Reduce Stress: While pregnancy for some can bring stress, try to find activities that help you release it.
Healthy Weight: Ensure that your weight is right, reduce your waist to bring it to a healthy range for a healthy pregnancy.
Food Habits: Stop eating junk and start eating more whole grains.
Exercise: A sedentary lifestyle can impact negatively on the child. You do not have to do HIIT, however, regular easy workouts can make both the pregnancy and delivery easy.
Dr Michelle Y Owens, professor of obstetrics and gynecology and a practicing maternal-fetal medicine specialist at the University of Mississippi Medical Center in Jackson, writes for the American College of Obstetricians and Gynecologists (ACOG) that "the longer your eggs have been around, the more likely they are to produce a pregnancy with a chromosome problem that can lead to a condition like Down syndrome. The risk goes up significantly after 35." However, she says, there is a good news. Now, we have tools to detect and respond to pregnancy complications early.
For many women, fertility can feel like a ticking clock, whether you’re planning to start a family soon or considering delaying pregnancy. One of the most useful tools for understanding your fertility potential is the AMH test, which measures the Anti-Müllerian Hormone in your blood.
But one question that often comes up is: “How often should I get my AMH levels checked?”
In this blog, we’ll break it down, explore what AMH tells you about your fertility, and provide practical guidance for testing frequency.
AMH is a hormone produced by small follicles in the ovaries. Its levels reflect your ovarian reserve, essentially the number of eggs remaining in your ovaries. While it doesn’t measure egg quality, AMH is a reliable indicator of egg quantity, making it a critical part of fertility assessments.
However, it’s important to remember that AMH is just one piece of the puzzle. Egg quality, age, lifestyle, and overall reproductive health also play crucial roles in fertility.
AMH levels vary from woman to woman and can be influenced by several factors:
| Factor | Effect on AMH Levels |
| Age | Declines naturally with age, especially after 35 |
| PCOS | Often higher than average due to increased follicles |
| Ovarian Surgery | Can lower AMH if ovarian tissue is removed |
| Chemotherapy/radiation | Can significantly reduce AMH |
| Lifestyle factors | Smoking, extreme stress, and poor nutrition may reduce AMH |
| Medications | Hormonal treatments can temporarily alter levels |
Here’s a general guide to what AMH levels mean at different ages:
| Age Group | AMH Range (ng/ml) | Interpretation |
| Under 25 | 3.0–6.8 | Excellent ovarian reserve |
| 25 - 30 | 2.5–5.0 | Good ovarian reserve |
| 31 - 35 | 1.5–4.0 | Slight decline; still healthy |
| 36 - 40 | 0.7–2.5 | Moderate decline; fertility may decrease |
| Over 40 | <1.0 | Low ovarian reserve; consider early action |
There is no universal answer, as testing frequency depends on your age, fertility goals, and medical history. Here’s a practical guide:
Under 35 and healthy: A single AMH test may be sufficient to establish a baseline.
Considering IVF or egg freezing: Your doctor may recommend repeating the test every 6–12 months to track ovarian response.
AMH declines more rapidly after 35, so annual testing is often advised.
Women with known fertility risks (e.g., endometriosis, previous ovarian surgery) may need testing every 6–12 months.
AMH is often elevated, which can mask fertility issues.
Testing may be less frequent unless undergoing fertility treatment.
AMH testing may be repeated every cycle to tailor medication dosage and predict egg retrieval numbers.
AMH levels can guide several important decisions:
| Goal | How AMH Helps |
| Egg freezing | Helps decide timing and number of eggs to retrieve |
| IVF Treatment | Predicts ovarian response and the number of eggs retrievable |
| Assessing natural fertility | Indicates remaining ovarian reserve and urgency for pregnancy |
By discussing your results with a fertility specialist at advanced centers like Birla Fertility & IVF, you can make informed, personalized decisions about family planning, IVF, or egg freezing.
While AMH is valuable, it has its limits:
AMH testing is a powerful tool for understanding ovarian reserve and guiding fertility decisions, but it’s not a standalone predictor of fertility. For most women, testing every 6–12 months is sufficient, with more frequent testing only in specific circumstances.
By knowing your AMH levels and consulting with a fertility specialist at centers like Birla Fertility & IVF, you can make proactive, informed choices about your reproductive health. Fertility may not wait for life to line up perfectly, but with the right guidance and planning, you can take steps toward your family goals with confidence.
Remember, AMH testing is a guide, not a verdict. It’s one step in understanding your fertility journey and making empowered decisions about your future.
Credits: Canva
In a study led by researchers at Mass General Brigham, pregnant individuals who stopped taking popular GLP-1 weight loss medications either before or early in their pregnancy were found to gain more weight and face higher risks of diabetes and hypertensive disorders during pregnancy.
They were also more likely to deliver preterm compared with people who had never taken GLP-1 drugs. The study, published in JAMA, shows that women who had used these drugs may face increased risks of preterm birth, diabetes, and pregnancy-related high blood pressure conditions such as preeclampsia compared with those who had not taken them.
GLP-1 medications include brands like Ozempic, Zepbound, Victoza, Trulicity, and Wegovy. They were originally developed to manage diabetes and control blood sugar but have become widely used for weight management and obesity treatment. These medicines may also help with conditions such as sleep apnea, improve heart and kidney health, and lower the risk of strokes.
Drugs like Ozempic and Wegovy belong to a class called glucagon-like peptide-1 (GLP-1) receptor agonists, which promote weight loss by mimicking a hormone that reduces appetite.
Many people regain weight after stopping these drugs, but pregnant women are generally advised against taking them. This has raised questions about how to safely help women wean off these medications around conception without increasing other health risks linked to obesity or diabetes.
The research team, led by Dr. Jacqueline Maya, looked at health records for nearly 1,800 pregnancies between 2016 and 2025, mostly among women with obesity. They found that women who stopped GLP-1 medications before or early in pregnancy gained an average of 7.2 pounds (3.27 kilograms) more than those who had never taken these drugs.
“The popularity of weight loss drugs has grown dramatically, but guidelines recommend stopping them before pregnancy because there isn’t enough safety data for unborn babies,” said Dr. Maya, a pediatric endocrinologist at Mass General Brigham for Children, as reported by Science Direct.
Women in the GLP-1 group also had a 32% higher risk of exceeding recommended pregnancy weight gain, a 30% higher risk of developing diabetes, a 29% higher risk of hypertensive disorders, and a 34% higher chance of preterm birth. Interestingly, there were no differences in C-section rates or babies’ birth weight and length.
Dr. Camille Powe, an endocrinologist and co-author of the study, noted that more research is needed to understand the benefits and risks of using GLP-1 drugs around pregnancy. “We need further studies to find ways to manage weight gain safely and reduce pregnancy risks when stopping GLP-1 medications,” Powe said, according to Science Direct.
Currently, there’s no safe role for GLP-1 use during pregnancy. No GLP-1 drugs are approved for expectant mothers.
Dr. Michael Snyder, MD, medical director of the Bariatric Surgery Center at Rose Medical Center and FuturHealth’s in-house obesity specialist, explains that human data on GLP-1s during pregnancy is very limited. Animal studies indicate potential risks including fetal growth restriction, pregnancy loss, and skeletal abnormalities at higher doses.
When someone takes a GLP-1 drug, their appetite changes, and it’s not yet clear how this could affect a pregnant person’s nutrition.
© 2024 Bennett, Coleman & Company Limited